Cargando…

A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma

SIMPLE SUMMARY: In the present study, we aimed to construct a methylation diagnostic tool using urine sediment for the detection of urothelial bladder carcinoma (UBC), and improved the diagnostic performance of the model by incorporating single nucleotide polymorphism sites. In stage I, single NRN1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Junjie, Xu, Ran, Lu, Qiang, Xu, Zhenzhou, Liu, Jianye, Li, Pei, Zhang, Yaqun, Zhou, Chuanchi, Luo, Lufeng, Tang, Wei, Wang, Zhenting, Cao, Manman, Cao, Jian, Xu, Genming, Wang, Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913436/ https://www.ncbi.nlm.nih.gov/pubmed/36765573 http://dx.doi.org/10.3390/cancers15030615

Ejemplares similares

Urine Cellular DNA Point Mutation and Methylation for Identifying Upper Tract Urinary Carcinoma
por: Ouyang, Wei, et al.
Publicado: (2022)

Immunohistochemical detection of hTERT in urothelial lesions: a potential adjunct to urine cytology
por: Khalbuss, Walid, et al.
Publicado: (2006)

Structural characterization of NrnC identifies unifying features of dinucleases
por: Lormand, Justin D, et al.
Publicado: (2021)

Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer
por: Facchinetti, Francesco, et al.
Publicado: (2023)

Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell‐free DNA in upper tract urothelial carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2019)

Role of FGFR3 in Urothelial Carcinoma
por: Akanksha, Malik, et al.
Publicado: (2019)

Structural Basis for the Bidirectional Activity of Bacillus nanoRNase NrnA
por: Schmier, Brad J., et al.
Publicado: (2017)

Correction: Structural characterization of NrnC identifies unifying features of dinucleases
por: Lormand, Justin D, et al.
Publicado: (2022)

NRN-EZ: an application to streamline biophysical modeling of synaptic integration using NEURON
por: Cobb, Evan A. W., et al.
Publicado: (2023)

Complexity of FGFR signalling in metastatic urothelial cancer
por: Rodriguez-Vida, Alejo, et al.
Publicado: (2015)

Urothelial carcinoma of the upper urinary tract diagnosed via FGFR3 mutation detection in urine: a case report
por: Silverberg, Daniel M
Publicado: (2012)

Immunotherapy With Checkpoint Inhibitors in FGFR-Altered Urothelial Carcinoma
por: Benjamin, David J, et al.
Publicado: (2022)

Case Report: Identification of Multiple TERT and FGFR2 Gene Fusions in a Pineal Region Glioblastoma Case
por: Guo, Xing, et al.
Publicado: (2021)

T152. NRN1 GENE AND FUNCTIONAL MRI: ASSOCIATION ANALYSIS IN SCHIZOPHRENIA PATIENTS AND HEALTHY SUBJECTS
por: Almodóvar, Carmen, et al.
Publicado: (2018)

NrnA is a 5′-3′ exonuclease that processes short RNA substrates in vivo and in vitro
por: Weiss, Cordelia A, et al.
Publicado: (2022)

Targeting the Src Pathway Enhances the Efficacy of Selective FGFR Inhibitors in Urothelial Cancers with FGFR3 Alterations
por: Lima, Nadia Carvalho, et al.
Publicado: (2020)

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
por: Guancial, Elizabeth A, et al.
Publicado: (2014)

Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer
por: Garje, Rohan, et al.
Publicado: (2020)

FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer
por: Kacew, Alec, et al.
Publicado: (2020)

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

The clinical and pathological relevance of waxy casts in urine sediment
por: Xu, Damin, et al.
Publicado: (2022)

TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas
por: Wang, Kun, et al.
Publicado: (2014)

BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
por: Kim, Se Hyun, et al.
Publicado: (2018)

ASP5878, a selective FGFR inhibitor, to treat FGFR3‐dependent urothelial cancer with or without chemoresistance
por: Kikuchi, Aya, et al.
Publicado: (2017)

Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer’s Disease
por: Hurst, Cheyenne, et al.
Publicado: (2023)

Bacillus subtilis NrnB is expressed during sporulation and acts as a unique 3′-5′ exonuclease
por: Myers, Tanner M, et al.
Publicado: (2023)

Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma
por: Lyou, Yung, et al.
Publicado: (2022)

Treatment approaches for FGFR-altered urothelial carcinoma: targeted therapies and immunotherapy
por: Benjamin, David J., et al.
Publicado: (2023)

TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance
por: Liu, Tiantian, et al.
Publicado: (2023)

NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches
por: Almodóvar-Payá, Carmen, et al.
Publicado: (2022)

Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma
por: Tsay, Ming-Dow, et al.
Publicado: (2019)

Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro
por: Pettitt, Geoffrey A, et al.
Publicado: (2022)

Koilocytes due to HPV in the urine sediment
por: Poloni, José Antonio Tesser, et al.
Publicado: (2020)

Evaluation of Urine Cytology in Urothelial Carcinoma Patients: A Comparison of CellprepPlus® Liquid-Based Cytology and Conventional Smear
por: Son, Seung-Myoung, et al.
Publicado: (2012)

Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience
por: Ji, Jin, et al.
Publicado: (2019)

The role of childhood adversities, FKBP5, BDNF, NRN1, and generalized self-efficacy in suicide attempts in alcohol-dependent patients
por: Berent, Dominika, et al.
Publicado: (2020)

FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma
por: Adib, Elio, et al.
Publicado: (2021)

SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7
por: Wang, Long, et al.
Publicado: (2020)

The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients
por: Yuan, Xiaotian, et al.
Publicado: (2016)

Cystinuria: urine sediment as a diagnostic test
por: Pierna, María, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_652f88d0uama3sju7v9vgvnsuf